Bone Infection
26
3
4
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
1 terminated out of 26 trials
93.3%
+6.8% vs benchmark
15%
4 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (26)
Side Effects of Antibiotics in Bone and Joint Infections
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
Biological Collection From Samples From The Gut Microbiota In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine (CARBAMICROBIOTA)
BonE and Joint Infections - Simplifying Treatment in Children Trial
Performances of DendrisCHIP®OA in Bone and Joint Infections
Oral-only Antibiotics for Bone and Joint Infections in Children
Initial Oral Antibiotics for Bone and Joint Infections in Children
ICG 24h Prior to Operative Treatment of Orthopaedic Infection
Hierarchy of Effects of Laboratory Markers and Their Interaction With Comorbidity Concerning Outcome and Personalized Treatment of Trauma Patients in Emergency Care and Rehabilitation
Cost of Off-label Antibiotics in Osteoarticular Infections
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
Alveolar Ridges Expansion Using Osseodensification Versus Screw Expansion Technique
Avis-PHAGEinLYON Clinic
Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy
Antimicrobial Synthetic Bone Grafts
Artificial Intelligence in the Diagnosis of Orthopaedic Conditions, Particularly Bone Tumours and Infection
Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Clinical Effectiveness of S53P4 Bioactive Glass in Treatment of Long-bone Chronic Osteomyelitis